COMBINATION THERAPY COMPRISING A TOR KINASE INHIBITOR AND N-(3-(5-FLUORO-2-(4-(2-METHOXYETHOXY)PHENYLAMINO)PYRIMIDIN-4- YLAMINO)PHENYL)ACRYLAMIDE FOR TREATING CANCER

• 收藏
• 分享

专利权人:

Signal Pharmaceuticals LLC

发明人:

HEGE, Kristen, Mae,克里斯汀.梅.海格,CHOPRA, Rajesh,拉杰什.喬普拉

申请号：

HK16109392.7

公开号：

HK1221168A

申请日:

2016.08.05

申请国别(地区):

HK

年份:

2017

代理人:

摘要：

Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount of N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide to a patient having a cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/